Eye & Facial Enhancements (Latisse & Upneeq)

Targeted Solutions for the Eye Area
Latisse and Upneeq offer prescription options for two distinct eye-area concerns. Latisse supports growth of inadequate or insufficient eyelashes, while Upneeq is an ophthalmic medication used to treat acquired drooping of the upper eyelid in adults.
%203%20(27)%20(1).jpg)
Prescription Treatment Based on Your Concern
Latisse contains bimatoprost and is applied nightly along the upper lash line to increase eyelash growth, including length, thickness, and darkness. Upneeq contains oxymetazoline and is used once daily as an eye drop to temporarily elevate acquired low-lying upper eyelids.
Because these medications treat different concerns, your provider first determines which option is appropriate. Prescription instructions, relevant medical history, eye conditions, and other medications are reviewed before treatment begins.
- Step 1: Meet with your provider to discuss your eye-area concern, medical history, and goals.
- Step 2: Your provider determines whether Latisse, Upneeq, or another approach is appropriate.
- Step 3: You receive individualized instructions for safe and consistent prescription use.
- Step 4: Treatment is used at home according to the prescribed application or dosing schedule.
- Step 5: Follow-up allows your provider to evaluate response and address any concerns.
%204%20(29)%20(1).jpg)
Am I a Good Candidate for Latisse or Upneeq?
These prescription treatments are intended for specific concerns rather than general cosmetic enhancement. Latisse may be considered for inadequate eyelashes, while Upneeq is indicated for adults with acquired blepharoptosis, or low-lying upper eyelids.
- Inadequate or sparse-looking eyelashes
- Short or lightly defined natural lashes
- Acquired low-lying upper eyelids
- Adults seeking nonsurgical ptosis treatment
- Patients appropriate for prescription eye-area therapy
Benefits and Outcomes
Latisse and Upneeq provide targeted prescription options for enhancing specific features around the eyes. Each works differently, allowing treatment to be matched to the concern rather than taking a one-size-fits-all approach.
Latisse is FDA-approved for eyelash hypotrichosis and can increase eyelash growth, including visible length, thickness, and darkness with consistent use.
As lashes become longer, thicker, and darker with Latisse, the lash line may appear more noticeable and naturally defined.
Upneeq is specifically FDA-approved to treat acquired blepharoptosis in adults, providing a prescription nonsurgical option for appropriate patients.
Upneeq works through its active ingredient, oxymetazoline, to temporarily elevate low-lying upper eyelids when used as prescribed.
Both treatments are used at home according to prescription instructions, allowing patients to incorporate them into a consistent daily routine.
Prescription oversight allows your provider to review candidacy, other eye medications, health considerations, and treatment response before and during use.
Tips for Safe Prescription Use
Results depend on the medication prescribed and consistent use. Latisse improvements develop gradually, while Upneeq is intended to provide a temporary eyelid-lifting effect with each prescribed dose.
Use your prescription exactly according to the dosing and application instructions provided.
Tell your provider about other eye medications, eye conditions, and relevant health changes.
Report persistent irritation, vision changes, or other concerning reactions promptly.
Avoid using more medication than prescribed in an attempt to improve results faster.
Avoid allowing applicators or medication containers to contact unintended surfaces or become contaminated.
Avoid continuing treatment without medical guidance if you develop concerning eye symptoms.
Any Questions?
Latisse is a prescription bimatoprost solution indicated for eyelash hypotrichosis. It increases eyelash growth, including length, thickness, and darkness.
Improvement develops gradually with continued use. The manufacturer describes increased eyelash fullness, length, and darkness over approximately 16 weeks, although individual results vary.
After treatment is discontinued, eyelash appearance is expected to gradually return toward its pretreatment level as lashes move through their natural growth cycle.
Upneeq is a prescription oxymetazoline ophthalmic solution indicated for the treatment of acquired blepharoptosis, or low-lying upper eyelids, in adults.
FDA labeling directs one drop into one or both affected eyes once daily. Contact lenses should be removed before use and may be reinserted 15 minutes afterward.
No. Both are prescription medications with specific indications, precautions, and potential side effects. Your provider should review your medical and eye history before prescribing either treatment.
What Our Patients Say
.jpg)
A Higher Standard for Health & Wellness
Vitality Health combines experienced clinical care, evidence-informed treatments, and a personalized approach to help patients pursue their health, wellness, and aesthetic goals with confidence.
Every experience is guided by thoughtful recommendations, high standards, and a commitment to quality care.
Invest in Your Health & Happiness
Take the next step toward your health, wellness, and aesthetic goals. Schedule your consultation with Vitality Health and discover a personalized approach designed around you.


%20(1).avif)
.avif)